Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Eschenhagen, Thomas  [Clear All Filters]
2021
Warnecke N, Ulmer BM, Laufer SD, Shibamiya A, Krämer E, Neuber C, Hanke S, Behrens C, Loos M, Münch J, et al. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy. Stem Cell Res. 2021;55:102489.
Eschenhagen T, Ridders K, Weinberger F. How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2021.
Stenzig J, Lemoine MD, Stoter AMS, Wrona KM, Lemme M, Mulla W, Etzion Y, Eschenhagen T, Hirt MN. Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue. J Mol Cell Cardiol. 2021.
Rhoden A, Friedrich FW, Brandt T, Raabe J, Schweizer M, Meisterknecht J, Wittig I, Ulmer BM, Klampe B, Uebeler J, et al. Sulforaphane exposure impairs contractility and mitochondrial function in three-dimensional engineered heart tissue. Redox Biol. 2021;41:101951.
de Boer RA, Heymans S, Backs J, Carrier L, Coats AJS, Dimmeler S, Eschenhagen T, Filippatos G, Gepstein L, Hulot J-S, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.
Flenner F, Jungen C, Küpker N, Ibel A, Kruse M, Koivumäki JT, Rinas A, Zech ATL, Rhoden A, Wijnker PJM, et al. Translational investigation of electrophysiology in hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2021.